This page includes the latest FDA filings for Patheon Inc Toronto Regional Operations. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
Device Company | Device | Date |
---|---|---|
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2024-07-13 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2024-03-15 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2023-01-24 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2022-12-21 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2021-12-01 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2021-03-07 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2019-12-21 |
Acorda Therapeutics, Inc., Alkermes Gainesville LLC, Sharp Corporation, Patheon Inc., Toronto Regional Operations, Alkermes Pharma Ireland Limited | Prescription Medication | 2017-10-12 |